BBIO vs HAS · rev $221.9M vs P/E 25, rev $4.75B
BridgeBio Pharma Inc (BBIO) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
BBIO currently screens at market cap $13.24B. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the BBIO and HAS stock pages for the full models.
Not investment advice.